Revolution Medicines, Inc. — All Filings
764 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001610717-25-000066 | Mar 14, 2025 | — |
| 144 | — | 0001610717-25-000063 | Mar 14, 2025 | — |
| 4 | — | 0001610717-25-000056 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001610717-25-000050 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001610717-25-000051 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001610717-25-000052 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001610717-25-000053 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001610717-25-000054 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001610717-25-000055 | Mar 4, 2025 | Mar 1, 2025 |
| S-8 | S-8 | 0001193125-25-036828 | Feb 26, 2025 | — |
| 8-K | 8-K | 0000950170-25-027707 | Feb 26, 2025 | — |
| 10-K | 10-K | 0000950170-25-027736 | Feb 26, 2025 | Dec 31, 2024 |
| 4 | — | 0001610717-25-000012 | Jan 22, 2025 | Jan 21, 2025 |
| 144 | — | 0001950047-25-000350 | Jan 21, 2025 | — |
| 4 | — | 0001610717-24-000548 | Dec 20, 2024 | Dec 18, 2024 |
| 4 | — | 0001610717-24-000546 | Dec 18, 2024 | Dec 16, 2024 |
| 4 | — | 0001610717-24-000547 | Dec 18, 2024 | Dec 16, 2024 |
| 4 | — | 0001610717-24-000545 | Dec 18, 2024 | Dec 16, 2024 |
| 4 | — | 0001610717-24-000543 | Dec 18, 2024 | Dec 16, 2024 |
| 4 | — | 0001610717-24-000544 | Dec 18, 2024 | Dec 16, 2024 |
| 144 | — | 0001610717-24-000540 | Dec 16, 2024 | — |
| 144 | — | 0001610717-24-000541 | Dec 16, 2024 | — |
| 144 | — | 0001610717-24-000537 | Dec 16, 2024 | — |
| 144 | — | 0001610717-24-000538 | Dec 16, 2024 | — |
| 144 | — | 0001610717-24-000539 | Dec 16, 2024 | — |
| 4 | — | 0001415889-24-028638 | Dec 9, 2024 | Dec 5, 2024 |
| 424B5 | 424B5 | 0001193125-24-270818 | Dec 5, 2024 | — |
| 8-K | 8-K | 0001193125-24-271540 | Dec 5, 2024 | Dec 3, 2024 |
| FWP | FWP | 0001193125-24-270186 | Dec 4, 2024 | — |
| 424B5 | 424B5 | 0001193125-24-269027 | Dec 2, 2024 | — |
| 8-K | 8-K | 0001193125-24-268404 | Dec 2, 2024 | — |
| 4 | — | 0001610717-24-000525 | Nov 19, 2024 | Nov 15, 2024 |
| 144 | — | 0001950047-24-008666 | Nov 15, 2024 | — |
| 4 | — | 0001610717-24-000522 | Nov 15, 2024 | Nov 13, 2024 |
| 144 | — | 0001950047-24-008534 | Nov 13, 2024 | — |
| SC 13G/A | SEC SCHEDULE 13G | 0000902219-24-000477 | Nov 8, 2024 | — |
| 4 | — | 0001610717-24-000518 | Nov 8, 2024 | Nov 6, 2024 |
| 8-K | 8-K | 0000950170-24-122266 | Nov 6, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-122303 | Nov 6, 2024 | Sep 30, 2024 |
| 144 | — | 0001950047-24-008202 | Nov 6, 2024 | — |
| 4 | — | 0001610717-24-000517 | Nov 5, 2024 | Nov 1, 2024 |
| 4 | — | 0001610717-24-000516 | Nov 4, 2024 | Oct 31, 2024 |
| 144 | — | 0001950047-24-008003 | Nov 1, 2024 | — |
| 144 | — | 0001950047-24-008004 | Nov 1, 2024 | — |
| 144 | — | 0001950047-24-008007 | Nov 1, 2024 | — |
| 144 | — | 0001950047-24-007972 | Oct 31, 2024 | — |
| 8-K | 8-K | 0001193125-24-243431 | Oct 25, 2024 | — |
| 8-K | 8-K | 0001193125-24-241397 | Oct 23, 2024 | — |
| 4 | — | 0001610717-24-000510 | Oct 16, 2024 | Oct 14, 2024 |
| 4 | — | 0001610717-24-000508 | Oct 15, 2024 | Oct 11, 2024 |